INTELLIA THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $45.26M, a 791.02% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $5.08M, a 39.57% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2019-09-30 was $19.07M.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $31.41M.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2018 was $28.55M, a 79.75% decline from fiscal 2017.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2017 was $141.00M, a 15.64% decline from fiscal 2016.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2016 was $167.14M, a 8324.34% increase from fiscal 2015.
- INTELLIA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2015 was $1.98M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-03-31 | $45.26M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $5.08M 10-Q · filed 2021-08-05 | |
| 2019-09-30 | $19.07M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $31.41M 10-Q · filed 2019-10-31 | |
| 2019-03-31 | $3.64M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $28.55M 10-K · filed 2019-02-27 | |
| 2017-12-31 | $141.00M 10-K · filed 2020-02-27 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $167.14M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | |
| 2015-12-31 | $1.98M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |